Literature DB >> 15831847

The influence of big pharma.

R E Ferner.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  2005        PMID： 15831847      PMCID： PMC556141          DOI： 10.1136/bmj.330.7496.855

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

2.  Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctors.

Authors:  Simon Maxwell; Tom Walley
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.

Authors:  C C Smith; P M Bennett; H M Pearce; P I Harrison; D J Reynolds; J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

5.  Newly licensed drugs.

Authors:  R E Ferner
Journal:  BMJ       Date:  1996-11-09

6.  The discovery of drug-induced illness.

Authors:  H Jick
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

7.  Whatalotwegot--the messages in drug advertisements.

Authors:  R E Ferner; D K Scott
Journal:  BMJ       Date:  1994 Dec 24-31

Review 8.  Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.

Authors:  David W J Clark; Deborah Layton; Saad A W Shakir
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
  8 in total
  8 in total

1.  Drug safety and regulation.

Authors:  Patrick C Waller; Stephen J W Evans; Keith Beard
Journal:  BMJ       Date:  2005-07-02

2.  Treating refractory epilepsy in adults.

Authors:  Edward Reynolds
Journal:  BMJ       Date:  2006-03-11

3.  [Economic public health significance of generic drugs].

Authors:  Doris Tschabitscher; Fabian Waechter; Marcus Müllner
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives.

Authors:  Janet Sultana; Ugo Moretti; Antonio Addis; Pia Caduff; Annalisa Capuano; Agnes Kant; Joan-Ramon Laporte; Marie Lindquist; June Raine; Daniele Sartori; Gianluca Trifirò; Marco Tuccori; Mauro Venegoni; Eugene van Puijenbroek; Roberto Leone
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

5.  Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson's in an international setting.

Authors:  Rejko Kruger; Inga Liepelt-Scarfone; Michele T Hu; Francesca Bowring; Jessica Welch; Charlotte Woodward; Christine Lo; Michael Lawton; Patricia Sulzer; Anne-Marie Hanff
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

6.  Suppressing Scientific Discourse on Vaccines? Self-perceptions of researchers and practitioners.

Authors:  Ety Elisha; Josh Guetzkow; Yaffa Shir-Raz; Natti Ronel
Journal:  HEC Forum       Date:  2022-05-19

7.  Understanding the pathogenesis of hip fracture in the elderly, osteoporotic theory is not reflected in the outcome of prevention programmes.

Authors:  Enrique Guerado; Rosa M Sandalio; Zaira Caracuel; Enrique Caso
Journal:  World J Orthop       Date:  2016-04-18

8.  Perspectives on the efficacy of antidepressants for child and adolescent depression.

Authors:  Amir Raz
Journal:  PLoS Med       Date:  2005-12-20       Impact factor: 11.069
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.